The HIV-1 Env gp120 Inner Domain Shapes the Phe43 Cavity and the CD4 Binding Site.


Journal

mBio
ISSN: 2150-7511
Titre abrégé: mBio
Pays: United States
ID NLM: 101519231

Informations de publication

Date de publication:
26 05 2020
Historique:
entrez: 28 5 2020
pubmed: 28 5 2020
medline: 10 4 2021
Statut: epublish

Résumé

The HIV-1 envelope glycoproteins (Env) undergo conformational changes upon interaction of the gp120 exterior glycoprotein with the CD4 receptor. The gp120 inner domain topological layers facilitate the transition of Env to the CD4-bound conformation. CD4 engages gp120 by introducing its phenylalanine 43 (Phe43) in a cavity ("the Phe43 cavity") located at the interface between the inner and outer gp120 domains. Small CD4-mimetic compounds (CD4mc) can bind within the Phe43 cavity and trigger conformational changes similar to those induced by CD4. Crystal structures of CD4mc in complex with a modified CRF01_AE gp120 core revealed the importance of these gp120 inner domain layers in stabilizing the Phe43 cavity and shaping the CD4 binding site. Our studies reveal a complex interplay between the gp120 inner domain and the Phe43 cavity and generate useful information for the development of more-potent CD4mc.

Identifiants

pubmed: 32457241
pii: mBio.00280-20
doi: 10.1128/mBio.00280-20
pmc: PMC7251204
pii:
doi:

Substances chimiques

CD4 Antigens 0
HIV Envelope Protein gp120 0
Phenylalanine 47E5O17Y3R

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : NIAID NIH HHS
ID : P01 AI150471
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI129769
Pays : United States
Organisme : NIGMS NIH HHS
ID : P01 GM056550
Pays : United States
Organisme : NIAID NIH HHS
ID : P01 AI131251
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI124982
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI145547
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI116274
Pays : United States
Organisme : NIAID NIH HHS
ID : R33 AI129017
Pays : United States
Organisme : NIAID NIH HHS
ID : R37 AI150590
Pays : United States
Organisme : CIHR
ID : 352417
Pays : Canada
Organisme : NIAID NIH HHS
ID : U01 AI150741
Pays : United States

Informations de copyright

Copyright © 2020 Prévost et al.

Références

J Virol. 2014 Nov;88(21):12895-906
pubmed: 25165110
J Infect Dis. 2009 Apr 1;199(7):1007-18
pubmed: 19231994
J Infect Dis. 2012 Aug 1;206(3):431-41
pubmed: 22634875
Proc Natl Acad Sci U S A. 2013 Apr 23;110(17):6626-33
pubmed: 23542380
Retrovirology. 2013 Dec 03;10:146
pubmed: 24299076
Nature. 1996 Nov 14;384(6605):184-7
pubmed: 8906796
Acta Crystallogr D Biol Crystallogr. 1994 Sep 1;50(Pt 5):760-3
pubmed: 15299374
Elife. 2018 Mar 21;7:
pubmed: 29561264
PLoS Pathog. 2017 Jul 31;13(7):e1006510
pubmed: 28759651
J Exp Med. 2014 Nov 17;211(12):2361-72
pubmed: 25385756
ACS Med Chem Lett. 2013 Mar 14;4(3):338-343
pubmed: 23667716
Science. 1996 Jun 28;272(5270):1955-8
pubmed: 8658171
J Virol. 2011 Jun;85(12):5949-60
pubmed: 21471235
J Virol. 2013 Mar;87(5):2549-62
pubmed: 23255784
J Virol. 2017 Mar 13;91(7):
pubmed: 28100618
PLoS Pathog. 2015 Mar 25;11(3):e1004767
pubmed: 25807248
J Virol. 2012 Sep;86(17):8974-86
pubmed: 22696649
J Med Chem. 2015 Sep 24;58(18):7603-8
pubmed: 26331669
J Virol. 2014 Jun;88(12):6542-55
pubmed: 24696475
Cell. 1996 Jun 28;85(7):1149-58
pubmed: 8674120
Nature. 2015 Jun 25;522(7557):487-91
pubmed: 25855300
Proc Natl Acad Sci U S A. 2014 Apr 29;111(17):6425-30
pubmed: 24733916
Acta Crystallogr D Biol Crystallogr. 2010 Jan;66(Pt 1):12-21
pubmed: 20057044
EBioMedicine. 2015 Dec 09;3:122-134
pubmed: 26870823
J Virol. 2018 Jun 13;92(13):
pubmed: 29669829
J Virol. 2019 Nov 26;93(24):
pubmed: 31554684
J Virol. 2016 Oct 28;90(22):10065-10073
pubmed: 27535053
J Virol. 2019 May 15;93(11):
pubmed: 30894474
Cell. 1999 Mar 5;96(5):667-76
pubmed: 10089882
Methods Enzymol. 1997;276:307-26
pubmed: 27754618
J Virol. 2002 Oct;76(19):9888-99
pubmed: 12208966
J Med Chem. 2012 May 10;55(9):4382-96
pubmed: 22497421
Cell. 1996 Jun 28;85(7):1135-48
pubmed: 8674119
Nat Struct Biol. 1995 Dec;2(12):1075-82
pubmed: 8846219
Cell Host Microbe. 2019 Apr 10;25(4):578-587.e5
pubmed: 30974085
Nat Commun. 2018 Jun 18;9(1):2363
pubmed: 29915222
J Virol. 2015 Jan;89(1):545-51
pubmed: 25339767
Structure. 2008 Nov 12;16(11):1689-701
pubmed: 19000821
J Virol. 2016 Apr 29;90(10):5031-5046
pubmed: 26962221
PLoS Biol. 2017 Apr 6;15(4):e2001549
pubmed: 28384158
Science. 2010 Dec 10;330(6010):1551-7
pubmed: 21051598
Proc Natl Acad Sci U S A. 2012 Apr 10;109(15):5663-8
pubmed: 22451932
J Virol. 2015 Dec 30;90(6):2993-3002
pubmed: 26719277
J Virol. 2009 May;83(9):4476-88
pubmed: 19211747
EMBO J. 1997 Feb 17;16(4):695-705
pubmed: 9049299
Nature. 1998 Jun 18;393(6686):648-59
pubmed: 9641677
EBioMedicine. 2016 Oct;12:208-218
pubmed: 27633463
J Virol. 2019 Jan 17;93(3):
pubmed: 30429344
J Biol Chem. 2012 Dec 14;287(51):43170-9
pubmed: 23100255
Proc Natl Acad Sci U S A. 2015 May 19;112(20):E2687-94
pubmed: 25941367
J Acquir Immune Defic Syndr. 2018 Jul 1;78(3):348-355
pubmed: 29528942
Nature. 2008 Sep 4;455(7209):109-13
pubmed: 18668044
J Virol. 2014 Jun;88(11):6031-46
pubmed: 24623433
J Virol. 2015 Dec 04;90(4):2127-34
pubmed: 26637462
PLoS Comput Biol. 2011 Oct;7(10):e1002195
pubmed: 22039361
Nature. 1996 Nov 14;384(6605):179-83
pubmed: 8906795
J Vis Exp. 2014 Sep 14;(91):51995
pubmed: 25286159
Genome Res. 2004 Jun;14(6):1188-90
pubmed: 15173120
Cell. 2014 Jul 31;158(3):481-91
pubmed: 25065977
Science. 1996 May 10;272(5263):872-7
pubmed: 8629022
J Virol. 2016 Sep 12;90(19):8395-409
pubmed: 27384653
J Virol. 2004 Apr;78(7):3742-52
pubmed: 15016894
Acta Crystallogr D Biol Crystallogr. 2004 Dec;60(Pt 12 Pt 1):2126-32
pubmed: 15572765
Nature. 1997 May 22;387(6631):426-30
pubmed: 9163431
Org Biomol Chem. 2017 Sep 26;15(37):7770-7782
pubmed: 28770939
PLoS One. 2014 Jan 28;9(1):e85940
pubmed: 24489681
Acta Crystallogr D Biol Crystallogr. 2002 Nov;58(Pt 11):1948-54
pubmed: 12393927
Antimicrob Agents Chemother. 2014 Sep;58(9):5478-91
pubmed: 25001301
PLoS Pathog. 2019 Jun 13;15(6):e1007819
pubmed: 31194843
Blood. 2011 Jan 6;117(1):145-55
pubmed: 20870901
Proc Natl Acad Sci U S A. 2016 Jun 14;113(24):E3413-22
pubmed: 27247400
Retrovirology. 2012 May 02;9:36
pubmed: 22551420
Nature. 1996 Jun 20;381(6584):661-6
pubmed: 8649511
Antimicrob Agents Chemother. 2012 Aug;56(8):4257-67
pubmed: 22615295
J Virol. 2006 Jan;80(2):835-44
pubmed: 16378985
PLoS Pathog. 2018 Aug 20;14(8):e1007238
pubmed: 30125330
J Virol. 2017 Jan 31;91(4):
pubmed: 27928014
J Virol. 2009 Sep;83(17):8364-78
pubmed: 19535453
Virology. 1981 Jul 15;112(1):355-60
pubmed: 6166122
Nature. 2019 Apr;568(7752):415-419
pubmed: 30971821
ACS Med Chem Lett. 2016 Jan 19;7(3):330-4
pubmed: 26985324
J Virol. 2017 Jan 18;91(3):
pubmed: 27881646
Biochemistry. 2006 Sep 12;45(36):10973-80
pubmed: 16953583
Mol Cell. 2010 Mar 12;37(5):656-67
pubmed: 20227370
Nature. 1990 Nov 1;348(6296):69-73
pubmed: 2172833
PLoS One. 2013 Aug 01;8(8):e69789
pubmed: 23936354
J Virol. 2014 Mar;88(5):2633-44
pubmed: 24352444
Virology. 2005 Sep 1;339(2):213-25
pubmed: 15996703
Nat Biotechnol. 2003 Jan;21(1):71-6
pubmed: 12483221
Viruses. 2019 Jan 16;11(1):
pubmed: 30654465
J Virol. 2017 May 12;91(11):
pubmed: 28331088
Biochemistry. 2012 Oct 2;51(39):7783-93
pubmed: 22963284
Science. 2014 Nov 7;346(6210):759-63
pubmed: 25298114
J Virol. 2015 Oct;89(20):10648-55
pubmed: 26269175
Nature. 1996 Jun 20;381(6584):667-73
pubmed: 8649512
J Infect Dis. 2018 Jul 2;218(3):471-475
pubmed: 29617845
J Exp Med. 2009 Jun 8;206(6):1273-89
pubmed: 19487424
Nat Struct Mol Biol. 2012 Sep;19(9):893-9
pubmed: 22864288
PLoS Pathog. 2012;8(5):e1002721
pubmed: 22693447
J Virol. 2012 Mar;86(5):2715-28
pubmed: 22190722
Syst Biol. 2010 May;59(3):307-21
pubmed: 20525638
Nature. 2013 Apr 25;496(7446):469-76
pubmed: 23552890
Virology. 2018 Feb;515:38-45
pubmed: 29248757
Structure. 2013 Jun 4;21(6):1018-29
pubmed: 23707685
Clin Immunol. 2007 Jul;124(1):57-68
pubmed: 17521962
Nat Commun. 2017 Oct 19;8(1):1049
pubmed: 29051495
Nature. 2012 Dec 6;492(7427):118-22
pubmed: 23103874

Auteurs

Jérémie Prévost (J)

Centre de Recherche du CHUM, Montreal, Quebec, Canada.
Département de Microbiologie, Infectiologie et Immunologie, Université de Montréal, Montreal, Quebec, Canada.

William D Tolbert (WD)

Infectious Diseases Division, Department of Medicine of Uniformed Services, University of the Health Sciences, Bethesda, Maryland, USA.

Halima Medjahed (H)

Centre de Recherche du CHUM, Montreal, Quebec, Canada.

Rebekah T Sherburn (RT)

Infectious Diseases Division, Department of Medicine of Uniformed Services, University of the Health Sciences, Bethesda, Maryland, USA.

Navid Madani (N)

Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
Department of Microbiology, Harvard Medical School, Boston, Massachusetts, USA.

Daria Zoubchenok (D)

Centre de Recherche du CHUM, Montreal, Quebec, Canada.
Département de Microbiologie, Infectiologie et Immunologie, Université de Montréal, Montreal, Quebec, Canada.

Gabrielle Gendron-Lepage (G)

Centre de Recherche du CHUM, Montreal, Quebec, Canada.

Althea E Gaffney (AE)

Department of Chemistry, University of Pennsylvania, Philadelphia, Pennsylvania, USA.

Melissa C Grenier (MC)

Department of Chemistry, University of Pennsylvania, Philadelphia, Pennsylvania, USA.

Sharon Kirk (S)

Department of Chemistry, University of Pennsylvania, Philadelphia, Pennsylvania, USA.

Natasha Vergara (N)

Department of Biochemistry and Molecular Biology, Drexel University College of Medicine, Philadelphia, Pennsylvania, USA.

Changze Han (C)

Department of Microbiology, Carver College of Medicine, University of Iowa, Iowa City, Iowa, USA.

Brendan T Mann (BT)

U.S. Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, Maryland, USA.
Henry M. Jackson Foundation for the Advancement of the Military Medicine, Bethesda, Maryland, USA.

Agnès L Chénine (AL)

U.S. Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, Maryland, USA.
Henry M. Jackson Foundation for the Advancement of the Military Medicine, Bethesda, Maryland, USA.

Adel Ahmed (A)

Department of Biochemistry and Molecular Biology, Drexel University College of Medicine, Philadelphia, Pennsylvania, USA.

Irwin Chaiken (I)

Department of Biochemistry and Molecular Biology, Drexel University College of Medicine, Philadelphia, Pennsylvania, USA.

Frank Kirchhoff (F)

Institute of Molecular Virology, Ulm University Medical Center, Ulm, Germany.

Beatrice H Hahn (BH)

Departments of Medicine and Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.

Hillel Haim (H)

Department of Microbiology, Carver College of Medicine, University of Iowa, Iowa City, Iowa, USA.

Cameron F Abrams (CF)

Department of Biochemistry and Molecular Biology, Drexel University College of Medicine, Philadelphia, Pennsylvania, USA.

Amos B Smith (AB)

Department of Chemistry, University of Pennsylvania, Philadelphia, Pennsylvania, USA.

Joseph Sodroski (J)

Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
Department of Microbiology, Harvard Medical School, Boston, Massachusetts, USA.

Marzena Pazgier (M)

Infectious Diseases Division, Department of Medicine of Uniformed Services, University of the Health Sciences, Bethesda, Maryland, USA.

Andrés Finzi (A)

Centre de Recherche du CHUM, Montreal, Quebec, Canada andres.finzi@umontreal.ca.
Département de Microbiologie, Infectiologie et Immunologie, Université de Montréal, Montreal, Quebec, Canada.
Department of Microbiology and Immunology, McGill University, Montreal, Quebec, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH